Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?

Stroke

Volumn 40, Issue 3, 2009, Pages 833-840

  Mayer, Stephan A ^a,h   Davis, Stephen M ^b   Skolnick, Brett E ^c   Brun, Nikolai C ^d   Begtrup, Kamilla ^d   Broderick, Joseph P ^e   Diringer, Michael N ^f   Steiner, Thorsten ^g  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NOVO NORDISK INC   (United States)

^d NOVO NORDISK A S   (Denmark)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Hemostatic therapy; Intracerebral hemorrhage; rFVIIa

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT PROTEIN;

AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; AGING; ANALYSIS OF VARIANCE; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; RISK; STATISTICAL MODEL; STROKE;

AGED; AGING; ANALYSIS OF VARIANCE; CEREBRAL HEMORRHAGE; FACTOR VIIA; FEMALE; HEMOSTATICS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; RECOMBINANT PROTEINS; STROKE; TREATMENT OUTCOME;

EID: 62449111837     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.524470     Document Type: Article

References (26)

1. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
2. Counsell C, Boonyakarnkul S, Dennis M, Sandercock P, Bamford J, Burn J, Warlow C. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project 2. Prognosis. Cerebrovasc Dis. 1995;5:26-34.
3. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023.
4. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke. 2000;31: 2511-2516.
5. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
6. Juvela S, Kase CS. Advances in intracerebral hemorrhage management. Stroke. 2006;37:301-304.
7. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
8. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66: 1175-1181.
9. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion. 2002;42:114-124.
10. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor Vila is independent of tissue factor. Br J Haematol. 1997;99:542-547.
11. Weiskopf RB. Recombinant-activated coagulation factor Vila (NovoSeven): current development. Vox Sang. 2007;92:281-288.
12. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis SM, Diringer MN, Skolnick BE, Steiner T; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VU for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137.
13. Mayer SA, Bran NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
14. Diringer MN, Skolnik BE, Mayer SA, Steiner T, Davis S, Brun NC, Broderick J. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke. 2008;39:850-856.
15. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.
16. Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martinez JJ, Gonzalez-Cornejo S. Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke. 2007;38:1641-1644.
17. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hier DB, Kase CS. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991;29:658-663.
18. Weimar C, Benemann J, Diener HC. Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry. 2006;77:601-605.
19. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, Skolnick BE, Davis SM. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery. 2006;59:767-773.
20. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003;34:224-229.
21. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316:1236-1238.
22. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999;30:2025-2032.
23. Kim J, Smith A, Hemphill JC III, Smith WS, Lu Y, Dillon WP, Wintermark M. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008;29: 520-525.
24. Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, Lev MH, Rosand J. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68: 889-894.
25. Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518-2525.
26. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.